Go Deep
Sanofi India Limited
Sanofi India Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 21,869 | 20.9 | 8.21 | 0.02 | 2,945.40 |
| Oct 2026 | 21,286 | 20.9 | 8.18 | 0.02 | 2,932.80 |
Sanofi India Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 4,377,000,000.0 | 4,723,000,000.0 | 4,198,000,000.0 | 4,063,000,000.0 |
| Net Profit | 835,000,000.0 | 1,026,000,000.0 | 617,000,000.0 | 695,000,000.0 |
| EPS | 36.3 | 44.5 | 26.8 | 30.2 |
Sanofi India Limited Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 18,234,000,000.0 | 19,890,000,000.0 | 19,816,000,000.0 | 27,272,000,000.0 | — |
| Net Profit | 3,267,000,000.0 | 4,135,000,000.0 | 6,029,000,000.0 | 6,206,000,000.0 | — |
| EPS | 141.8 | 179.5 | 261.8 | 269.5 | — |
Sanofi India Limited Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 12,548,000,000.0 | 16,118,000,000.0 | 17,148,000,000.0 | 20,717,000,000.0 | — |
| Total Liabilities | 5,056,000,000.0 | 7,512,000,000.0 | 6,996,000,000.0 | 7,959,000,000.0 | — |
| Total Equity | 7,492,000,000.0 | 8,606,000,000.0 | 10,152,000,000.0 | 12,758,000,000.0 | — |
Owes vs Owns
Sanofi India Limited owed ₹0.41 for every ₹1 it owned in Jun 2026, up from ₹0.38 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.41× | 0.40× | 0.47× | 0.41× | 0.38× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Sanofi India Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Dec 2025
Cash & short-term investments 21.0%Receivables 14.1%Inventory 24.8%Fixed assets (tangible) 25.3%Long-term investments 0.5%Other assets 14.2%
How it's funded — Dec 2025
Long-term debt 1.1%Payables 15.5%Other liabilities 23.4%Shareholders' equity 59.7%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 262.9 | 283.8 | 394.5 | 1,004.9 |
| Receivables | 176.7 | 230.0 | 131.7 | 129.1 |
| Inventory | 311.6 | 499.8 | 663.8 | 408.0 |
| Fixed assets (tangible) | 317.7 | 329.9 | 325.3 | 328.1 |
| Intangible assets | 0.7 | 1.3 | 7.5 | 5.1 |
| Long-term investments | 6.8 | 0.0 | 11.1 | 14.7 |
| Other assets | 178.4 | 267.0 | 180.9 | 181.8 |
| Liabilities & equity | ||||
| Short-term debt | 4.1 | 5.3 | 5.1 | 8.7 |
| Long-term debt | 13.7 | 14.0 | 13.9 | 14.9 |
| Payables | 194.0 | 406.3 | 291.5 | 356.4 |
| Other liabilities | 293.8 | 325.6 | 389.1 | 415.9 |
| Shareholders' equity | 749.2 | 860.6 | 1,015.2 | 1,275.8 |
| Net tangible assets | 748.5 | 859.3 | 1,007.7 | 1,270.7 |
Sanofi India Limited Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 4,383,000,000.0 | 4,617,000,000.0 | 2,304,000,000.0 | 3,987,000,000.0 | — |
| Investing Activities | -113,000,000.0 | -192,000,000.0 | 375,000,000.0 | 6,509,000,000.0 | — |
| Financing Activities | -4,479,000,000.0 | -3,924,000,000.0 | -8,783,000,000.0 | -15,827,000,000.0 | — |